How to Get Vardenafil (Levitra/Staxyn) in South Dakota

Vardenafil Prescribing Rules in South Dakota

South Dakota permits vardenafil prescriptions through both in-person visits and telehealth encounters. The state does not classify vardenafil as a controlled substance, which simplifies the prescribing process compared to medications on the South Dakota Board of Pharmacy schedules.

Who Can Write the Prescription

Any physician (MD or DO) licensed in South Dakota can prescribe vardenafil after a clinical evaluation. Nurse practitioners hold full practice authority in South Dakota under SDCL 36-9A, meaning they can independently evaluate, diagnose, and prescribe without a collaborative agreement. Physician assistants may also prescribe vardenafil, though they must maintain a supervisory relationship with a licensed physician per South Dakota law.

Telehealth Prescribing Standards

South Dakota's telehealth statutes allow a valid prescriber-patient relationship to be established through real-time audio-video encounters. A prescriber located out of state must hold a South Dakota medical license or be registered through the Interstate Medical Licensure Compact, of which South Dakota is a member state. The prescriber must document the clinical encounter, confirm the patient's identity, and verify their South Dakota location at the time of the visit.

Prescription Validity and Refills

A vardenafil prescription in South Dakota is valid for up to 12 months from the date written. Because vardenafil is not a controlled substance, prescribers can authorize refills within that window. Most telehealth platforms issue prescriptions in 90-day supplies with refills, which reduces pharmacy visits for patients in rural parts of the state.

Clinical Requirements Before Starting Vardenafil

Prescribers should complete a cardiovascular and sexual health assessment before writing a vardenafil prescription. This is not optional. The FDA-approved labeling for vardenafil includes specific contraindications that require screening.

Required Medical History

The evaluation must cover current medications (particularly nitrates and alpha-blockers), cardiovascular history, hepatic function, and any history of priapism or Peyronie's disease. Vardenafil is contraindicated with nitrates in any form. Concomitant use of alpha-blockers requires dose adjustment, starting at 5 mg per the FDA label.

Lab Work

Routine lab panels are not universally mandated before prescribing vardenafil, but most clinicians order a baseline set to rule out underlying conditions that mimic or worsen ED. A reasonable pre-prescribing panel includes:

• Fasting glucose or HbA1c (screening for diabetes, present in roughly 50% of men with ED)
• Lipid panel (cardiovascular risk assessment)
• Total testosterone (to identify hypogonadism as a contributing factor)
• Basic metabolic panel (renal and hepatic function, relevant for dose adjustment)

Vardenafil requires dose reduction to 5 mg in patients with moderate hepatic impairment (Child-Pugh B) and is not recommended in severe hepatic impairment.

Cardiovascular Screening

The American College of Cardiology and AHA guidelines recommend that men with ED undergo cardiovascular risk stratification. ED often precedes coronary artery disease by 3 to 5 years. A resting ECG may be appropriate for men over 40 with additional risk factors. Vardenafil causes a mean QTc prolongation of approximately 8 ms at the 10 mg dose, so prescribers should avoid it in patients with congenital QT prolongation or those taking Class IA or III antiarrhythmics.

Vardenafil Efficacy: What the Evidence Shows

Vardenafil has a well-established evidence base for ED treatment across severity levels.

Key Trial Data

In the key fixed-dose trial by Porst et al. (2003, N=580), vardenafil 20 mg improved the International Index of Erectile Function (IIEF) erectile function domain score by a mean of 9.1 points from baseline compared to 3.4 points with placebo. Successful intercourse attempts reached 75% in the 20 mg group versus 39% with placebo.

Onset and Duration

Vardenafil reaches peak plasma concentration in approximately 60 minutes under fasting conditions. A high-fat meal delays absorption by about 60 minutes and reduces Cmax by 18% to 50%. The clinical effect window extends to roughly 4 to 5 hours, though individual responses vary. Staxyn (the orally disintegrating tablet formulation) should not be taken with liquid and is not interchangeable with standard vardenafil tablets due to different bioavailability profiles.

Head-to-Head Context

A meta-analysis published in BJU International (2009) comparing PDE5 inhibitors found no statistically significant difference in overall efficacy between vardenafil 20 mg, sildenafil 100 mg, and tadalafil 20 mg for general ED populations. The clinical choice often depends on patient preference for onset speed, duration of action, or side-effect profile rather than raw efficacy differences.

Pharmacy Access in South Dakota

South Dakota's pharmacy infrastructure includes retail chains, independent pharmacies, mail-order services, and licensed 503A compounding facilities.

Retail and Chain Pharmacies

Generic vardenafil is stocked at most retail pharmacies across South Dakota, including locations in Sioux Falls, Rapid City, Aberdeen, and Brookings. Chains like Lewis Drug (a South Dakota-based regional chain), Walgreens, and CVS carry generic vardenafil. Cash prices for generic vardenafil 20 mg tablets typically range from $8 to $25 per tablet depending on quantity and pharmacy, though prices fluctuate. GoodRx-type discount cards can reduce this further.

Mail-Order Pharmacy

For patients in rural areas (South Dakota ranks 46th in population density among U.S. States), mail-order pharmacy is practical. Licensed mail-order pharmacies can ship vardenafil to any South Dakota address. Telehealth platforms that prescribe vardenafil often partner with mail-order pharmacies to send medications directly, with typical delivery windows of 3 to 7 business days.

503A Compounding Pharmacies

South Dakota licenses 503A compounding pharmacies under the South Dakota Board of Pharmacy. These facilities can prepare vardenafil in custom dosage forms (sublingual troches, combination formulations with other PDE5 inhibitors or ingredients) when a prescriber writes a patient-specific prescription. A 503A pharmacy must compound in response to an individual prescription and cannot produce bulk inventory for general distribution.

Compounded vardenafil is not FDA-approved and is not AB-rated to commercial products, so the prescriber should document a clinical rationale for compounding (allergy to an inactive ingredient, need for a dose not commercially available, or combination therapy).

Insurance and Cost in South Dakota

Most patients in South Dakota will encounter mixed coverage for vardenafil depending on their insurance type.

South Dakota Medicaid

South Dakota Medicaid does not cover vardenafil or other PDE5 inhibitors for erectile dysfunction. This policy aligns with CMS guidance that allows state Medicaid programs to exclude ED drugs from formularies. Patients on South Dakota Medicaid must pay entirely out of pocket.

Commercial Insurance

Coverage for vardenafil varies by plan. Many commercial insurers cover generic vardenafil with quantity limits (typically 6 to 12 tablets per month) and may require prior authorization. Brand-name Levitra and Staxyn are rarely covered, as generics became available in 2018. Patients should verify formulary placement with their specific plan.

Medicare Part D

Medicare Part D plans have excluded coverage of ED medications since the Medicare Modernization Act of 2003. This exclusion applies to all PDE5 inhibitors, including vardenafil. Medicare Advantage plans occasionally offer supplemental coverage, but this is uncommon for ED drugs.

Reducing Out-of-Pocket Cost

Three strategies work in South Dakota:

1. Generic substitution. Always request generic vardenafil rather than brand Levitra. The price difference can be 80% or more.
2. Quantity negotiation. Some pharmacies offer lower per-tablet pricing at higher quantities (e.g., 30-count versus 6-count).
3. Compounded formulations. 503A pharmacies sometimes offer combination troches at a lower per-dose cost than retail generics, though quality can vary between compounders.

Prior Authorization in South Dakota

When commercial insurance does cover vardenafil, prior authorization (PA) is a common requirement. The PA process in South Dakota follows the insurer's protocol, not a state-specific form.

Typical Documentation Required

Most PA requests for vardenafil require:

• A confirmed diagnosis of erectile dysfunction (ICD-10 code N52.x)
• Documentation that the patient has tried and failed, or has a contraindication to, another PDE5 inhibitor (step therapy)
• Prescriber attestation that the medication is not for cosmetic purposes
• Relevant lab results (testosterone level, HbA1c if diabetic)

Processing Timeline

PA decisions in South Dakota must follow the insurer's standard timelines. For commercial plans, initial decisions typically arrive within 48 to 72 hours. Urgent requests may be processed within 24 hours. If denied, patients can appeal through the insurer's internal process or file a complaint with the South Dakota Division of Insurance.

Telehealth Platforms Serving South Dakota

Multiple telehealth platforms prescribe vardenafil to South Dakota residents. A valid platform must use prescribers licensed in South Dakota and comply with state telehealth regulations.

What to Look For

A legitimate telehealth ED provider should offer synchronous (live) audio-video consultation, not just an asynchronous questionnaire. South Dakota law requires that a prescriber-patient relationship be established before prescribing. Platforms that rely solely on intake forms without any real-time clinician interaction may not meet this standard.

Typical Telehealth Workflow

1. Complete an online intake form with medical history, current medications, and symptom details.
2. Schedule or join a live video consultation with a licensed prescriber.
3. The prescriber reviews your history, discusses treatment options, and orders labs if needed.
4. If appropriate, the prescriber sends a vardenafil prescription to your chosen pharmacy or the platform's partner pharmacy.
5. Medication ships to your South Dakota address or is available for pickup.

Most platforms complete this process within 24 to 48 hours from initial intake to prescription submission.

Transferring a Vardenafil Prescription to South Dakota

Patients relocating to South Dakota or traveling within the state can transfer an existing vardenafil prescription.

Because vardenafil is not a controlled substance, prescription transfers between pharmacies are straightforward. The receiving South Dakota pharmacy contacts the originating pharmacy to verify and transfer the remaining refills. Interstate transfers follow the same process, provided the prescription was written by a prescriber whose license is recognized in the originating state.

If you are moving permanently, establishing care with a South Dakota-licensed prescriber ensures uninterrupted access. A telehealth visit with a new provider typically takes 15 to 30 minutes and results in a new prescription that avoids transfer complications entirely.

Safety Monitoring After Starting Vardenafil

Once a patient begins vardenafil, follow-up evaluation is recommended within 4 to 8 weeks. This visit assesses efficacy, side effects, and whether dose adjustment is needed.

Common Side Effects

The most frequently reported adverse effects in clinical trials include headache (15%), flushing (11%), rhinitis (9%), and dyspepsia (4%), based on pooled data from the FDA prescribing information. These effects are dose-dependent and generally mild.

When to Seek Immediate Care

Patients should go to an emergency department for erections lasting longer than 4 hours (priapism), sudden vision loss in one or both eyes (possible non-arteritic anterior ischemic optic neuropathy, or NAION), or sudden hearing decrease. These events are rare but require urgent intervention.

The AUA guideline on erectile dysfunction (2018) recommends that prescribers counsel patients on these warning signs at the time of prescribing and document that counseling occurred.